Monitoring response to preventive therapy in patients with Huntington's disease (HD) using 18F-labeled fluorodeoxyglucose PET (FDG-PET) imaging

2013 Science-Business eXchange  
doi:10.1038/scibx.2013.1045 fatcat:b3rr43iytbam3j2aj5s44sgfmy